Evidence map›Paper›PMID 28781679›Full record

ArticleOncology letters2017

TRAF6 expression is associated with poorer prognosis and high recurrence in urothelial bladder cancer.

Hanli Wu, Aixia Hao, Honghong Cui, Wenbin Wu, Huanrong Yang, Baohong Hu, Peng Li

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hanli WuDepartment of Nephrology, Yidu Central Hospital of Weifang, Weifang, Shandong 262500, P.R. China.
Aixia HaoDepartment of Nephrology, Yidu Central Hospital of Weifang, Weifang, Shandong 262500, P.R. China.
Honghong CuiDepartment of Nephrology, Yidu Central Hospital of Weifang, Weifang, Shandong 262500, P.R. China.
Wenbin WuDepartment of Nephrology, Yidu Central Hospital of Weifang, Weifang, Shandong 262500, P.R. China.
Huanrong YangDepartment of Nephrology, Yidu Central Hospital of Weifang, Weifang, Shandong 262500, P.R. China.
Baohong HuEast District of Shandong Provincial Hospital of Shandong Univeristy, Jinan, Shandong 250014, P.R. China.
Peng LiDepartment of Medical Oncology, Yantai Yuhuangding Hospital Affiliated to Qingdao University, Yantai, Shandong 264000, P.R. China.
Yidu Central Hospital of Weifang · CNQingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to investigate the clinical significance of TNF receptor-associated factor 6 (TRAF6) expression in urothelial bladder cancer. TRAF6 expression was detected by immunohistochemistry in 126 samples of patients with urothelial bladder cancer. The association between clinicopathological factors and TRAF6 expression was analyzed by χ

Indexed as

metastasisprognosisrecurrenceTNF receptor-associated factor 6urothelial bladder cancer

Identifiers

PMID28781679
PMCPMC5530217
OpenAlexW2699101192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.